Dublin, March 21, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Hospital Acquired Infection (HAI) Control Markets" report to their offering. Hospital Acquired Infection (HAI) Control Markets provides a revenue analysis for the prevention, testing, and treatment of infections in the healthcare surroundings, including the world revenues for 2010-2021 for hospital infection control, for hospital infection treatment, and for hospital infection prevention equipment and consumables (sterilization/disinfection).
Sales information is also provided for the different market segments by primary geographic region (United States, Europe, rest of world) and leading manufacturers' shares.
Merck, Pfizer, GlaxoSmithKline, and Bayer are among the key companies in HAI control markets are among those manufacturers featured in the report's competitor analysis. Key Topics Covered: CHAPTER ONE: EXECUTIVE SUMMARY OVERVIEW THE NOSOCOMIAL INFECTION MARKET SCOPE RESEARCH METHODOLOGY INDUSTRY CHALLENGES TOTAL SIZE AND GROWTH OF THE MARKET ISSUES AND TRENDS AFFECTING MARKET CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS OVERVIEW Introduction to Pathogens Classification of Antibacterial Organisms COMMON HOSPITAL (NOSOCOMIAL) INFECTIONS DESCRIPTION OF INFECTIONS Acinetobacter Baumannii Clostridium Difficile Gastroenteritis Hospital-Acquired Pneumonia (HAP) Pseudomonas Aeruginosa Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus Stenotrophomonas Maltophilia Tuberculosis Urinary Tract Infections Vancomycin-Resistant Enterococcus Ventilator-Associated Pneumonia (VAP) Patient Risk Factors General Populations at Risk for Infection Hospital Acquired Infection (HAI) Control Markets WORLD DEMOGRAPHICS Assessing the Problem: Nosocomial Infection Statistics Hospital Length of Stay U.S. GOVERNMENT'S NATIONAL PLAN TO PREVENT HEALTHCARE ASSOCIATED INFECTIONS (HAIS) STEERING COMMITTEE EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES AFFORDABLE CARE ACT (ACA) FUNDING EMERGING INFECTIONS PROGRAM THE DEPARTMENT OF HEALTH AND HUMAN SERVICES: 2017 BUDGET HIGHLIGHTS NATIONAL HEALTHCARE SAFETY NETWORK HEALTHCARE INFECTION SURVEILLANCE PROCESS PHARMACEUTICAL MANUFACTURER AND MARKETER TRENDS Trends in Partnerships and Alliances Developers Trends CHAPTER THREE: INFECTION PREVENTION OVERVIEW MARKET OVERVIEW Healthcare Infection Prevention Market by Geographical Region Methods of Transmission HIGH-RISK FACILITIES OR DEPARTMENTS Acute Care Hospitals Long-term Care Facilities Outpatient Settings Technology Overview Sterilization vs. Disinfection EQUIPMENT AND SOLUTIONS HEAT/STEAM STERILIZATION Product Examples CHEMICAL AND GAS STERILIZATION Disinfecting Agents and Medical Device Components Sterilants Product Examples Mid-Level Disinfectants RADIATION STERILIZATION Product Examples COMPETITIVE ANALYSIS CHAPTER FOUR: INFECTION TESTING OVERVIEW TOTAL MARKET SIZE AND FORECAST Healthcare Infection Testing Market by Geographical Region TESTING FOR NOSOCOMIAL INFECTIONS Drug-Resistance/Susceptibility Testing Genotypic Methods DNA Sequencing Solid-phase Hybridization Techniques Hospital Acquired Infection (HAI) Control Markets Microarrays Real-time Polymerase Chain Reaction Techniques Phenotypic Methods Phage-based Assays Colorimetric Methods The Nitrate Reductase Assay Chromogenic Testing SPECIFIC SERIOUS HEALTHCARE INFECTION TESTING Acinetobacter Baumannii Carbapenem-resistant Enterobacteriaceae Clostridium Difficile Product Examples Hospital-Acquired Pneumonia Pseudomonas Aeruginosa Staphylococcus Aureus Ventilator-Associated Pneumonia DEVELOPMENTS COMPETITIVE ANALYSIS CHAPTER FIVE: INFECTION TREATMENT OVERVIEW TOTAL MARKET SIZE AND FORECAST Healthcare Infection Treatment Market by Geographical Region PRINCIPLES OF ANTI-BACTERIAL THERAPY Infecting Organism Antibiotic Sensitivity Testing Site of Infection Host Defenses and Organ Function Antibiotic Pharmacokinetics Monitoring Therapy CLASSIFICATIONS OF ANTIBACTERIAL PRODUCTS Aminoglycosides Carbapenems Cephalosporins Glycopeptides Macrolides Penicillins Quinolones Sulfonamides Tetracyclines MARKET SIZE AND SALES DISTRIBUTION BY ANTIBIOTIC CLASS INFECTIONS AND DRUG RESISTANCE Easing Approvals of Antibiotics QUALIFIED INFECTIOUS DISEASE PROGRAM DESIGNATIONS Causes of Drug Resistance Drug Resistance in Select Populations Treatment Guidelines NEW DEVELOPMENTS New Developments in Biotherapies for Infection Treatment COMPETITIVE ANALYSIS Leading Products CHAPTER SIX: MARKET OPPORTUNITIES FOR HOSPITAL INFECTION CONTROL MARKET CONSIDERATIONS MARKET OVERVIEW Healthcare-Acquired Infection Distribution by Setting Healthcare Infection Control Market by Geographical Region Developed and Emerging Market Analysis CHAPTER SEVEN: COMPANY PROFILES INTRODUCTION 3M Abbott Laboratories Abbvie Advanced Sterilization Products Alere Astrazeneca Bayer Becton, Dickinson And Company Belimed Biomérieux S.A. Cantel Medical Corp. Danaher Corporation Getinge Group Glaxosmithkline Plc Merck & Co. Pfizer, Inc. Roche Sakura Seiki Co., Ltd. Steris Plc Tso3, Inc. For more information about this report visit http://www.researchandmarkets.com/research/rb...l_acquired
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Antibiotics
